Hillel v. Obvio Health USA, Inc.

CourtDistrict Court, S.D. New York
DecidedJanuary 21, 2021
Docket1:20-cv-04647
StatusUnknown

This text of Hillel v. Obvio Health USA, Inc. (Hillel v. Obvio Health USA, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Hillel v. Obvio Health USA, Inc., (S.D.N.Y. 2021).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK IRIS HILLEL, Plaintiff, -against- OBVIO HEALTH USA, INC.; OBVIO No. 20-CV-4647 (LAP) HEALTH PTE. LTD.; SPRIM AMERICAS, INC.; IQVIA, INC.; MICHAEL OPINION & ORDER SHLEIFER, IVAN JARRY, PRASANNA PITALE, ALISTAIR GRENFELL, DIKLA SHPANGENTAL, and ANAND THARMARATNAM in their individual and professional capacities, Defendants.

LORETTA A. PRESKA, Senior United States District Judge: Before the Court are (1) Defendant IQVIA Inc.’s (“IQVIA”) motion to dismiss and to strike pursuant to Federal Rules of Civil Procedure 12(b)(6) and 12(f)1 and (2) Defendants Prasanna Pitale, Alistair Grenfell, Dikla Shpangental, and Anand Tharmaratnam’s (collectively, the “Individual Defamation Defendants”) motion to dismiss pursuant to Federal Rules of

1 (See Notice of Defendant IQVIA Inc.’s Motion to Dismiss and to Strike Pursuant to Federal Rules of Civil Procedure 12(b)(6) and 12(f) (“IQVIA MTD”), dated Aug. 31, 2020 [dkt. no. 31]; see also Memorandum of Law in Support of Defendant IQVIA Inc.’s Motion to Dismiss and To Strike Pursuant to Fed. R. Civ. P. 12(b)(6) and 12(f) (“IQVIA Br.”), dated Aug. 31, 2020 [dkt. no. 32]; Reply Memorandum in Further Support of Defendant IQVIA Inc.’s Motion to Dismiss and To Strike Pursuant to Fed. R. Civ. P. 12(b)(6) and 12(f), dated Oct. 13, 2020 [dkt. no. 51].) Civil Procedure 12(b)(2) and 12(b)(6).2 Plaintiff Iris Hillel opposes the motions.3 For the reasons below, the motions to dismiss are GRANTED, and the motion to strike is DENIED as moot. I. Background

Between 2004 and 2012, Plaintiff worked for both IMS Holdings, Inc. (“IMS”) and Quintiles Transnational Holdings, Inc. (“Quintiles”) in various management positions. (Amended Complaint (“Am. Compl.”), dated July 30, 2020 [dkt. no. 25] ¶¶ 24-25.) After Plaintiff left Quintiles, IMS and Quintiles merged and “[t]he combined organization was renamed IQVIA.” (Id. ¶ 26.) Between 2013 and 2019, Plaintiff held various senior management roles at other healthcare and life-sciences companies. (Id. ¶¶ 27-29.)

2 (See Notice of Motion to Dismiss Pursuant to Federal Rules of Civil Procedure 12(b)(2) and 12(b)(6) by Defendants Prasanna Pitale, Alistair Grenfell, Dikla Shpangental, and Anand Tharmaratnam (“Ind. Defs. MTD”), dated Aug. 31, 2020 [dkt. no. 34]; Memorandum of Law in Support of Motion to Dismiss Pursuant to Fed. R. Civ. P. 12(b)(2) and 12(b)(6) by Defendants Prasanna Pitale, Alistair Grenfell, Dikla Shpangental, and Anand Tharmaratnam, dated Aug. 31, 2020 [dkt. no. 34]; Reply Memorandum in Further Support of Motion to Dismiss Pursuant to Fed. R. Civ. P. 12(b)(2) and 12(b)(6) by Defendants Pitale, Grenfell, Shpangental, and Tharmaratnam, dated Oct. 13, 2020 [dkt. no. 52].) 3 (See Plaintiff Iris Hillel’s Memorandum of Law in Opposition to Defendant IQVIA, Inc.’s Motion to Dismiss and Strike (“Pl. Opp. to IQVIA”), dated Sept. 28, 2020 [dkt. no. 48]; Plaintiff Iris Hillel’s Memorandum of Law in Opposition to Defendants Prasanna Pitale, Alistair Grenfell, Dikla Shpangental, and Anand Tharmaratnam’s Motion to Dismiss (“Pl. Opp. to Ind. Defs.”), dated Sept. 28, 2020 [dkt. no. 47].) In August 2019, Plaintiff joined Defendants Obvio Health USA, Inc. and Obvio Health Pte. Ltd. (collectively, “Obvio”) as CEO.4 At the time of Plaintiff’s hiring, Obvio and IQVIA were

“in the process of negotiating a large deal.” (Id. ¶ 104.) Given Plaintiff’s knowledge of IQVIA obtained from her past employment, she “began working on the deal immediately.” (Id. ¶ 105.) In the process, she worked closely with both IQVIA’s legal team and Defendant Prasanna Pitale, a Senior Vice President of Global Consumer Health at IQVIA and a member of Obvio’s Board of Directors. (Id. ¶¶ 15, 105.) However, Ms. Hillel’s course of employment at Obvio quickly took a turn for the worse. Only one week after Ms. Hillel joined Obvio, Defendant Anand Tharmaratnam, IQVIA’s then- President of Asia Pacific, informed Defendant Michael Shleifer5 and non-party Laurent Benissan that Plaintiff had been fired

from IMS. (Id. ¶¶ 18, 106.) As a result of Mr. Tharmaratnam’s statement, Plaintiff was required to provide Obvio with a “copy of her resignation letter to assure them that she was telling the truth about her resignation from IMS.” (Id. ¶ 112.)

4 (Am. Compl. ¶¶ 8-10, 30.) Defendant SPRIM Americas, Inc. (“SPRIM”) is Obvio’s parent company. (Id. ¶¶ 11, 31.) Neither SPRIM nor Obvio joins the motions to dismiss. 5 Mr. Shleifer is the Co-Founder and Managing Partner of SPRIM. (Id. ¶ 13.) Mr. Shleifer does not join either motion to dismiss. Shortly thereafter, on December 20, 2019, Plaintiff learned from Defendant Ivan Jarry6 that Mr. Pitale had “informed him of two additional . . . statements” made about her by IQVIA

employees. (Id. ¶ 114.) First, Defendant Alistair Grenfell, IQVIA’s President for Europe, the Middle East, Africa and South Asia, said that he “did not want Ms. Hillel to work with IQVIA in Europe.” (Id. ¶¶ 16, 115.) Second, Dikla Shpangental, IQVIA’s Vice President for Israel, “stated that she would not attend any meetings with ObvioHealth if Ms. Hillel was going to be present.” (Id. ¶¶ 17, 116.) Those statements, which were made shortly before the Obvio-IQVIA deal was set to close, left Plaintiff “dumbfounded” because “she had never had any issues working with any of these individuals” and both knew of her “exemplary performance” and “positive relationships with IQVIA employees and clients.” (Id. ¶¶ 117, 120, 123, 129.)

Plaintiff asserts that there are no legitimate business reasons for Mr. Tharmaratnam, Mr. Pitale, Mr. Grenfell, and Ms. Shpangental to have made those statements. (Id. ¶¶ 110, 121, 124, 137.) Instead, Plaintiff suggests that those declarations were made (1) to harm her professional reputation and to interfere with her employment at Obvio and (2) to undermine

6 Mr. Jarry is Obvio’s current CEO and a Co-Founder and Managing Partner of SPRIM. (Am. Compl. ¶ 14.) Mr. Jarry does not join in either motion to dismiss. Obvio’s efforts to consummate deals with third parties that would have been competitive to IQVIA’s services. (Id. ¶¶ 110, 121, 124, 129-132, 134, 136.) Under the terms of their deal,

Obvio could continue such work during a six-month transition period following the deal’s closing. (Id. ¶¶ 129-132.) Events came to a boil on March 23, 2020. That morning, Ms. Hillel was in a car accident, which required her to be hospitalized. (Id. ¶¶ 156-157.) A few hours after informing Mr. Jarry of the accident, Plaintiff received an email from Cheryl Walter, Chief Talent Officer at SPRIM, informing her that her employment was being terminated. (Id. ¶ 159.) Plaintiff’s termination letter stated that she was “unable to perform or execute the full range of duties expected of the Chief Executive Officer of Obvio.” (Id. ¶ 160.) Plaintiff alleges that her firing was caused, at least in part, by the IQVIA employees’

statements. (Id. ¶¶ 164-165.) A few months later, Plaintiff filed this action, asserting, inter alia, claims for defamation, defamation per se, and tortious interference with prospective economic relations. (See Complaint, dated June 17, 2020, [dkt. no.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Keeton v. Hustler Magazine, Inc.
465 U.S. 770 (Supreme Court, 1984)
Calder v. Jones
465 U.S. 783 (Supreme Court, 1984)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Chloé v. Queen Bee of Beverly Hills, LLC
616 F.3d 158 (Second Circuit, 2010)
Chandok v. Klessig
632 F.3d 803 (Second Circuit, 2011)
Licci Ex Rel. Licci v. Lebanese Canadian Bank, SAL
673 F.3d 50 (Second Circuit, 2012)
Kirch v. Liberty Media Corp.
449 F.3d 388 (Second Circuit, 2006)
V.S. Ex Rel. T.S. v. Muhammad
595 F.3d 426 (Second Circuit, 2010)
Fischbarg v. Doucet
880 N.E.2d 22 (New York Court of Appeals, 2007)
Carvel Corp. v. Noonan
818 N.E.2d 1100 (New York Court of Appeals, 2004)
NBT Bancorp Inc. v. Fleet/Norstar Financial Group, Inc.
664 N.E.2d 492 (New York Court of Appeals, 1996)
World Wrestling Federation Entertainment, Inc. v. Bozell
142 F. Supp. 2d 514 (S.D. New York, 2001)
Fuji Photo Film U.S.A., Inc. v. McNulty
669 F. Supp. 2d 405 (S.D. New York, 2009)

Cite This Page — Counsel Stack

Bluebook (online)
Hillel v. Obvio Health USA, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/hillel-v-obvio-health-usa-inc-nysd-2021.